These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17920383)

  • 1. Statins and vitamin D.
    Aloia JF; Li-Ng M; Pollack S
    Am J Cardiol; 2007 Oct; 100(8):1329. PubMed ID: 17920383
    [No Abstract]   [Full Text] [Related]  

  • 2. Alendronate with and without cholecalciferol for osteoporosis: results of a 15-week randomized controlled trial.
    Recker R; Lips P; Felsenberg D; Lippuner K; Benhamou L; Hawkins F; Delmas PD; Rosen C; Emkey R; Salzmann G; He W; Santora AC
    Curr Med Res Opin; 2006 Sep; 22(9):1745-55. PubMed ID: 16968578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcifediol improves lipid profile in osteopenicatorvastatin-treated postmenopausal women.
    Catalano A; Morabito N; Basile G; Cucinotta D; Lasco A
    Eur J Clin Invest; 2015 Feb; 45(2):144-9. PubMed ID: 25483366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D status and response to daily 400 IU vitamin D3 and weekly alendronate 70 mg in men and women with osteoporosis.
    Karaplis AC; Chouha F; Djandji M; Sampalis JS; Hanley DA
    Ann Pharmacother; 2011 May; 45(5):561-8. PubMed ID: 21521859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alendronate and calcifediol compared to alendronate and cholecalciferol in osteoporotic patients.
    Giampà E; Di Bonito M; Ferretti V; Nuvoli G; Paoletti F; Piazzini M; Ranieri M; Tuveri MA; Vinicola V
    Minerva Endocrinol; 2019 Dec; 44(4):344-350. PubMed ID: 31971357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium/vitamin D
    Liao EY; Zhang ZL; Xia WB; Lin H; Cheng Q; Wang L; Hao YQ; Chen DC; Tang H; Peng YD; You L; He L; Hu ZH; Song CL; Wei F; Wang J; Zhang L
    BMC Musculoskelet Disord; 2018 Jul; 19(1):210. PubMed ID: 29970059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vitamin D supplements. Recommended doses are not enough].
    Díez Pérez A
    Med Clin (Barc); 2012 Mar; 138(5):202-3. PubMed ID: 22197369
    [No Abstract]   [Full Text] [Related]  

  • 8. Can vitamin D metabolite measurements facilitate a "treat-to-target" paradigm to guide vitamin D supplementation?
    Binkley N; Lappe J; Singh RJ; Khosla S; Krueger D; Drezner MK; Blank RD
    Osteoporos Int; 2015 May; 26(5):1655-60. PubMed ID: 25572049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of vitamin D dose on bone mineral density.
    Heaney RP
    Osteoporos Int; 2012 Feb; 23(2):789-90; author reply 791. PubMed ID: 22113323
    [No Abstract]   [Full Text] [Related]  

  • 10. Vitamin D deficiency in a cohort of patients with systemic scleroderma from the south of Spain.
    Rios Fernández R; Fernández Roldán C; Callejas Rubio JL; Ortego Centeno N
    J Rheumatol; 2010 Jun; 37(6):1355; author reply 1356. PubMed ID: 20516041
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of vitamin D status on the effect of statins on bone mineral density and bone turnover markers in postmenopausal women.
    Hernández JL; Olmos JM; Romaña G; Llorca J; Martínez J; Castillo J; de Juan J; Pérez-Pajares I; Ruiz S; González-Macías J
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3304-9. PubMed ID: 24878047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vitamin D status in osteoporotic postmenopausal women taking oral recommended vitamin D supplementation].
    Ivorra J; Valls E; Fernández-Llanio Comella N; Chalmeta Verdejo I; Oliver Oliver MJ; Román Ivorra JA
    Med Clin (Barc); 2012 Mar; 138(5):199-201. PubMed ID: 22197363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of parathyroid hormone and alendronate alone or in combination in osteoporosis.
    Fuller KE
    N Engl J Med; 2004 Jan; 350(2):189-92; author reply 189-92. PubMed ID: 14714278
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcitriol treatment in patients with low vitamin D levels.
    Tanakol R; Gül N; Üzüm AK; Aral F
    Arch Osteoporos; 2018 Oct; 13(1):114. PubMed ID: 30353299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in 25-Hydroxyvitamin D3 to oral treatment with vitamin D3 in postmenopausal females with osteoporosis.
    Hoeck HC; Li B; Qvist P
    Osteoporos Int; 2009 Aug; 20(8):1329-35. PubMed ID: 19083075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of vitamin D insufficiency with combined strontium ranelate and vitamin D3 in osteoporotic patients.
    Rizzoli R; Dawson-Hughes B; Kaufman JM; Fardellone P; Brandi ML; Vellas B; Collette J; Reginster JY
    Eur J Endocrinol; 2014 Mar; 170(3):441-50. PubMed ID: 24322182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D replacement in pregnant women in rural north India: a pilot study.
    Roth DE
    Eur J Clin Nutr; 2010 Aug; 64(8):914-5; author reply 915-6. PubMed ID: 20160749
    [No Abstract]   [Full Text] [Related]  

  • 18. Vitamin D insufficiency does not affect response of bone mineral density to alendronate.
    Antoniucci DM; Vittinghoff E; Palermo L; Black DM; Sellmeyer DE
    Osteoporos Int; 2009 Jul; 20(7):1259-66. PubMed ID: 19043656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D deficiency, myositis-myalgia, and reversible statin intolerance.
    Glueck CJ; Budhani SB; Masineni SS; Abuchaibe C; Khan N; Wang P; Goldenberg N
    Curr Med Res Opin; 2011 Sep; 27(9):1683-90. PubMed ID: 21728907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different strategies of 25OH vitamin D supplementation in HIV-positive subjects.
    Falasca K; Ucciferri C; Di Nicola M; Vignale F; Di Biase J; Vecchiet J
    Int J STD AIDS; 2014 Oct; 25(11):785-92. PubMed ID: 24469972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.